{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:59Z","timestamp":1790870039882,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ijmm.2003.12.002","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T19:25:31Z","timestamp":1093375531000},"page":"35-44","source":"Crossref","is-referenced-by-count":30,"title":["Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination"],"prefix":"10.1016","volume":"294","author":[{"given":"Ulrike K","family":"Hahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Alex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-Peter","family":"Czerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2003.12.002_BIB1","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/intimm\/9.12.1897","article-title":"Influence of cellular location of expressed antigen on the efficacy of DNA vaccination","volume":"9","author":"Boyle","year":"1997","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB4","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1016\/S0264-410X(01)00151-7","article-title":"Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein","volume":"19","author":"Bucht","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB6","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB7","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2672.1999.00898.x","article-title":"Immune correlates of protection against anthrax","volume":"87","author":"Fowler","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","article-title":"Re-examination and further development of a precise and rapid dye method for measuring cell growth\/cell kill","volume":"119","author":"Hansen","year":"1989","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00152686","article-title":"Recent advances in the development of an improved human anthrax vaccine","volume":"4","author":"Ivins","year":"1988","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","article-title":"Immunization against anthrax with aromatic compound-dependent (aro\u2212) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume":"58","author":"Ivins","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB14","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB15","series-title":"Toxins and Virulence Factors in Disease \u2013 Bacterial Handbook of Natural Toxins","first-page":"543","article-title":"Anthrax toxins","author":"Leppla","year":"1995"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1438-4221(00)80056-9","article-title":"Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs","volume":"290","author":"Pellizzari","year":"2000","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB17","first-page":"130","article-title":"Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax","volume":"87","author":"Pitt","year":"1996","journal-title":"Salisbury Med. Bull."},{"issue":"32","key":"10.1016\/j.ijmm.2003.12.002_BIB18","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB19","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB20","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB21","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1521-4141(200103)31:3<692::AID-IMMU692>3.0.CO;2-Y","article-title":"Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequences from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection","volume":"31","author":"Scheiblhofer","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB23","first-page":"143","article-title":"Designing immune responses with genetic immunization and immunostimulatory DNA sequences","volume":"35","author":"Thalhamer","year":"2001","journal-title":"Endocr. Regul."},{"issue":"Special Suppl.","key":"10.1016\/j.ijmm.2003.12.002_BIB24","first-page":"89","article-title":"Protection conferred by microbially supplemented UK and purified PA vaccines","volume":"68","author":"Turnbull","year":"1990","journal-title":"Proc. Int. Workshop Anthrax Salisbury Med. Bull."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect. Immun."},{"issue":"Special Suppl.","key":"10.1016\/j.ijmm.2003.12.002_BIB26","first-page":"49","article-title":"Pathogenesis and host resistance to Bacillus anthracis","volume":"68","author":"Welkos","year":"1990","journal-title":"Salisbury Med. Bull."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/mpat.1993.1037","article-title":"Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice","volume":"14","author":"Welkos","year":"1993","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijmm.2003.12.002_BIB28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.ijmm.2003.12.002_BIB29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","article-title":"Presentation of protective antigen to the mouse immune system","volume":"87","author":"Williamson","year":"1999","journal-title":"J. Appl. Microbiol."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422104000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422104000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T06:47:22Z","timestamp":1682750842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422104000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1438422104000050"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2003.12.002","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}